Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc.verified

BLPH

Price:

$0.012

Market Cap:

$146.79K

Bellerophon Therapeutics, Inc. is a U.S.-based clinical-stage pharmaceutical company primarily focused on developing novel therapies for various cardiopulmonary conditions. Its flagship product is INOpulse, a proprietary platform designed to deliver pulsatile nitric oxide, specifically targeting pulmonary hypertension (PH). The company is actively advancing the development of INOpulse across multiple indications: Currently, INOpulse is undergoing a Phase 3 clinical trial for pulmonary hypertension linked to fibrotic interstitial lung disease. It has successfully completed a Phase 2a trial for pulmonary hypertension tied to chronic obstructive pulmonary disease. Furthermore, a Phase 2 dose es...[Read more]

Industry

Biotechnology

IPO Date

2015-02-13

Stock Exchange

NASDAQ

Ticker

BLPH

The PE Ratio as of June 2026 (TTM) for Bellerophon Therapeutics, Inc. (BLPH) is -0.01

According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -100.91% compared to the average of 1.48 of the last 4 quarters.

Bellerophon Therapeutics, Inc. (BLPH) Historical PE Ratio (quarterly & annually)

How has BLPH PE Ratio performed in the past?

The mean historical PE Ratio of Bellerophon Therapeutics, Inc. over the last ten years is -5.38. The current -0.01 PE Ratio has changed -74.93% with respect to the historical average. Over the past ten years (40 quarters), BLPH's PE Ratio was at its highest in in the March 2018 quarter at 7.24. The PE Ratio was at its lowest in in the June 2015 quarter at -33.15.

Quarterly (TTM)
Annual

Average

-5.38

Median

-1.97

Minimum

-28.01

Maximum

18.52

Bellerophon Therapeutics, Inc. (BLPH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 18.02%

Maximum Annual PE Ratio = 18.52

Minimum Annual Increase = -1110.45%

Minimum Annual PE Ratio = -28.01

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.43-73.87%
2021-1.66-21.11%
2020-2.1018.02%
2019-1.78-109.62%
201818.52-1110.45%
2017-1.83-25.58%
2016-2.46-65.73%
2015-7.19-73.23%
2014-26.84-4.16%
2013-28.01-25.44%

Bellerophon Therapeutics, Inc. (BLPH) Average PE Ratio

How has BLPH PE Ratio performed in the past?

The current PE Ratio of Bellerophon Therapeutics, Inc. (BLPH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.40

5-year avg

2.51

10-year avg

-5.38

Bellerophon Therapeutics, Inc. (BLPH) PE Ratio vs. Peers

How is BLPH’s PE Ratio compared to its peers?

Bellerophon Therapeutics, Inc.’s PE Ratio is greater than Atlantic International Corp. (-0.55), greater than Akerna Corp. (-3.98), less than Histogen Inc. (-0.01), less than Virios Therapeutics, Inc. (0.00), greater than Seelos Therapeutics, Inc. (-0.05), less than TFF Pharmaceuticals, Inc. (-0.01), greater than Immatics N.V. (-5.07), less than TC Biopharm (Holdings) Plc (-0.00), greater than BioCardia, Inc. (-1.22),

Build a custom stock screener for Bellerophon Therapeutics, Inc. (BLPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellerophon Therapeutics, Inc. (BLPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bellerophon Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Bellerophon Therapeutics, Inc. (BLPH)?

What is the highest PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?

What is the 3-year average PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?

What is the 5-year average PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?

How does the current PE Ratio for Bellerophon Therapeutics, Inc. (BLPH) compare to its historical average?